Description of Collaborative Activity: |
This behavioral research study is evaluating whether non-daily medication regimens for HIV Pre-Exposure Prophylaxis (PrEP) may be more acceptable and foster better adherence to product. PrEP represents a novel biomedical approach to HIV prevention, in which individuals at-risk for HIV take antiretroviral medications to help prevent HIV infection. The HPTN 067 study is conducted through the NIAID-led HIV Prevention Trials Network. An Inter-Agency Agreement between NIMH and CDC supports the implementation of this international research study at a clinical research site in Bangkok Thailand. |
